Intelligent Medicine Exchange (IMX)
Kevin Ioannacci, CFE has extensive work experience in the financial industry, with their most recent role being the Director of Market Surveillance at Intelligent Medicine Exchange (IMX) since October 2022. Prior to that, they worked at the National Futures Association as a Trade Specialist - Market Regulation from November 2013 to October 2022. Kevin also held positions at various companies including PrinceRidge LLC, Wall Street Access, Incapital, Vining Sparks, BMO Capital Markets, Loop Capital Markets, and J.P. Morgan Capital Markets / BancOne Capital Markets in roles such as Executive Director, Vice President, and Senior Vice President. Kevin'sexpertise lies in institutional and broker dealer sales, municipal bond sales, institutional fixed income sales, and market surveillance.
Kevin Ioannacci, CFE completed their high school education at Crystal Lake South High School in 1979. Afterward, they attended Elmhurst University, where they earned a Bachelor of Arts (BA) degree in Geography and the Environment. The exact dates of their enrollment at Elmhurst University are not provided.
This person is not in any teams
Intelligent Medicine Exchange (IMX)
IMX Health is the first financial futures exchange for the healthcare industry. In addition to offering hedging opportunities for payers, providers, and other market participants in the healthcare industry, IMX will create a transparent, two-sided market for pricing healthcare assets. Patients will also benefit from increased competition forservices and lower prices and premiums as a result of this.